The Mohamed bin Zayed University of Artificial Intelligence is exploring how artificial intelligence can help translate genomics into more useful clinical information. In a report on its Global Genomics Summit, MBZUAI described work combining genetic data with clinical records, biological measurements, lifestyle information and wearable-device data.
The research challenge is larger than sequencing DNA. Genomic information can indicate a predisposition to disease, but health outcomes are also shaped by age, environment, diet, activity and biological processes that change over time. Combining those sources creates a more complete picture, but it also introduces complex data-management, privacy and validation requirements.
MBZUAI’s Human Phenotype Project is one example of this approach. The project combines genomic information with clinical records and measurements including blood tests, proteins, metabolites, microbiome data, imaging, sleep, nutrition, lifestyle and wearable signals. AI can help identify patterns across those layers that would be difficult to detect by examining one variable at a time.
The UAE’s healthcare system is already part of the story. At the summit, the Department of Health – Abu Dhabi described the use of genomics in cancer diagnosis and treatment, cardiovascular disease prevention and pharmacogenomics, with genetic information integrated into Malaffi, Abu Dhabi’s health information exchange. Pharmacogenomics can help clinicians consider whether genetic differences may affect a patient’s response to a medicine.
The opportunity is substantial, but the work is not a simple model deployment. Population data must represent the people who will benefit from the resulting systems. Models need clinical validation, transparent limitations and safeguards for sensitive genetic information. Doctors also need guidance and training if predictions are to be interpreted correctly at the point of care.
MBZUAI’s announcement therefore represents a research and translation agenda rather than a claim that an autonomous clinical system is ready for general use. Its importance lies in connecting UAE AI research, national genomic data and healthcare infrastructure. The next measure will be evidence that these systems improve diagnosis, prevention or treatment decisions while preserving consent, privacy and clinical accountability.
